The use of extracorporeal carbon dioxide removal to avoid intubation in patients failing non-invasive ventilation - a cost analysis

BMC Anesthesiology

Volumn 15, Issue 1, 2015, Pages

  Braune, Stephan ^a   Burchardi, Hilmar ^b   Engel, Markus ^c   Nierhaus, Axel ^a   Ebelt, Henning ^d   Metschke, Maria ^a   Rosseau, Simone ^e   Kluge, Stefan ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Department of Cardiology and Intensive Care ^*  (Germany)

^c KLINIKUM BOGENHAUSEN   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Carbon dioxide removal; Cost analysis; Extracorporeal; Mechanical ventilation; Treatment costs

Indexed keywords

ACUTE ON CHRONIC VENTILATORY INSUFFICIENCY; ARTERIOVENOUS EXTRACORPOREAL CARBON DIOXIDE REMOVAL; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; COST CONTROL; ECONOMIC EVALUATION; EXTRACORPOREAL OXYGENATION; HOSPITAL COST; HUMAN; HYPERCAPNIA; INTENSIVE CARE; LENGTH OF STAY; LUNG ASSIST DEVICE; NONINVASIVE VENTILATION; RETROSPECTIVE STUDY; TREATMENT FAILURE; CASE CONTROL STUDY; CLINICAL TRIAL; ECONOMICS; EXTRACORPOREAL CIRCULATION; HOSPITALIZATION; INTENSIVE CARE UNIT; METABOLISM; MULTICENTER STUDY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY; STATISTICS AND NUMERICAL DATA;

CARBON DIOXIDE;

CARBON DIOXIDE; CASE-CONTROL STUDIES; EXTRACORPOREAL CIRCULATION; HOSPITALIZATION; HUMANS; HYPERCAPNIA; INTENSIVE CARE UNITS; LENGTH OF STAY; NONINVASIVE VENTILATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 84946213916     PISSN: None     EISSN: 14712253     Source Type: Journal    
DOI: 10.1186/s12871-015-0139-0     Document Type: Article

References (34)

1. Kahn JM, Le T, Angus DC, Cox CE, Hough CL, White DB, et al. The epidemiology of chronic critical illness in the United States. Crit Care Med. 2015;43:282-7.
2. Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369:2126-36.
3. Jaber S, Jung B, Matecki S, Petrof BJ. Clinical review: ventilator-induced diaphragmatic dysfunction - human studies confirm animal model findings! Crit Care. 2011;15:206.
4. Timsit JF, Zahar JR, Chevret S. Attributable mortality of ventilator-associated pneumonia. Curr Opin Crit Care. 2011;17:464-71.
5. Agerstrand CL, Bacchetta MD, Brodie D. ECMO for adult respiratory failure: current use and evolving applications. ASAIO J. 2014;60:255-62.
6. Terragni PP, Birocco A, Faggiano C, Ranieri VM. Extracorporeal CO2 removal. Contrib Nephrol. 2010;165:185-96.
7. Kluge S, Braune SA, Engel M, Nierhaus A, Frings D, Ebelt H, et al. Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation. Intensive Care Med. 2012;38:1632-9.
8. Burki NK, Mani RK, Herth FJ, Schmidt W, Teschler H, Bonin F, et al. A novel extracorporeal CO(2) removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPD. Chest. 2013;143:678-86.
9. Crotti S, Lissoni A, Tubiolo D, Azzari S, Tarsia P, Caspani L, et al. Artificial lung as an alternative to mechanical ventilation in COPD exacerbation. Eur Respir J. 2012;39:212-5.
10. Del Sorbo SL, Pisani L, Filippini C, Fanelli V, Fasano L, Terragni P, et al. Extracorporeal Co2 removal in hypercapnic patients at risk of noninvasive ventilation failure: a matched cohort study with historical control. Crit Care Med. 2015;43:120-7.
11. Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD. 2012;9:131-41.
12. Nevins ML, Epstein SK. Predictors of outcome for patients with COPD requiring invasive mechanical ventilation. Chest. 2001;119:1840-9.
13. Esteban A, Anzueto A, Frutos F, Alia I, Brochard L, Stewart TE, et al. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA. 2002;287:345-55.
14. Ucgun I, Metintas M, Moral H, Alatas F, Yildirim H, Erginel S. Predictors of hospital outcome and intubation in COPD patients admitted to the respiratory ICU for acute hypercapnic respiratory failure. Respir Med. 2006;100:66-74.
15. Texereau J, Jamal D, Choukroun G, Burgel PR, Diehl JL, Rabbat A, et al. Determinants of mortality for adults with cystic fibrosis admitted in Intensive Care Unit: a multicenter study. Respir Res. 2006;7:14.
16. Menzies R, Gibbons W, Goldberg P. Determinants of weaning and survival among patients with COPD who require mechanical ventilation for acute respiratory failure. Chest. 1989;95:398-405.
17. Combes A, Costa MA, Trouillet JL, Baudot J, Mokhtari M, Gibert C, et al. Morbidity, mortality, and quality-of-life outcomes of patients requiring > or = 14 days of mechanical ventilation. Crit Care Med. 2003;31:1373-81.
18. Pfeifer M. Chronic critically ill patients from a pneumological perspective. Med Klin Intensivmed Notfmed. 2013;108:279-84.
19. Bein T, Weber F, Philipp A, Prasser C, Pfeifer M, Schmid FX, et al. A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med. 2006;34:1372-7.
20. Novalung GmbH. Annual Business Report. 2014. http://www.novalung.com. Accessed 27 June 2015.
21. Jegers M, Edbrooke DL, Hibbert CL, Chalfin DB, Burchardi H. Definitions and methods of cost assessment: an intensivist's guide. ESICM section on health research and outcome working group on cost effectiveness. Intensive Care Med. 2002;28:680-5.
22. Moerer O, Plock E, Mgbor U, Schmid A, Schneider H, Wischnewsky MB, et al. A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units. Crit Care. 2007;11:R69.
23. Consumer price index and inflation rates. German Federal Statistical Office. https://www.destatis.de/EN/Homepage.html. Accessed 27 June 2015
24. Rapoport J, Teres D, Zhao Y, Lemeshow S. Length of stay data as a guide to hospital economic performance for ICU patients. Med Care. 2003;41:386-97.
25. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765-73.
26. Parviainen I, Herranen A, Holm A, Uusaro A, Ruokonen E. Results and costs of intensive care in a tertiary university hospital from 1996-2000. Acta Anaesthesiol Scand. 2004;48:55-60.
27. Edbrooke DL, Minelli C, Mills GH, Iapichino G, Pezzi A, Corbella D, et al. Implications of ICU triage decisions on patient mortality: a cost-effectiveness analysis. Crit Care. 2011;15:R56.
28. Edbrooke D, Hibbert C, Ridley S, Long T, Dickie H. The development of a method for comparative costing of individual intensive care units. The Intensive Care Working Group on Costing. Anaesthesia. 1999;54:110-20.
29. Flaatten H, Kvale R. Cost of intensive care in a Norwegian University hospital 1997-1999. Crit Care. 2003;7:72-8.
30. Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med. 2005;33:1266-71.
31. Heyland DK, Gafni A, Kernerman P, Keenan S, Chalfin D. How to use the results of an economic evaluation. Crit Care Med. 1999;27:1195-202.
32. Makris D, Desrousseaux B, Zakynthinos E, Durocher A, Nseir S. The impact of COPD on ICU mortality in patients with ventilator-associated pneumonia. Respir Med. 2011;105:1022-9.
33. Norris C, Jacobs P, Rapoport J, Hamilton S. ICU and non-ICU cost per day. Can J Anaesth. 1995;42:192-6.
34. Gyldmark M. A review of cost studies of intensive care units: problems with the cost concept. Crit Care Med. 1995;23:964-72.